Clinical Trials Directory

Trials / Unknown

UnknownNCT05693753

Xenogenic Collagen Matrix for the Treatment of Multiple Gingival Recessions

Coronally Advanced Flap With Xenogenic Collagen Matrix or Autogenous Connective Tissue Graft for the Treatment of Multiple Adjacent Gingival Recessions: a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Turin, Italy · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary aim of this study is to evaluate whether the use of a xenogenic collagen matrix (XCM) for the treatment of multiple adjacent gingival recessions (MAGRs) with a multiple coronally advanced flap technique (mCAF) achieves better results than the use of an autologous connective tissue graft (CTG) in terms of recession reduction (primary outcome) and other secondary root coverage outcomes (e.g. complete root coverage, mean root coverage). Moreover, this study aims to compare secondary clinical variables (e.g. keratinized tissue width (KTW) changes, probing pocket depth (PPD) changes, volumetric gain (VG), etc.), also with a digital approach, the patient-reported outcome measures (PROMs e.g. pain, swelling, bleeding). The hypothesis of this study is that at 6 months and 1 year follow-up the mCAF with XCM is not inferior to CTG in terms of recessions reduction and secondary clinical variables, and superior regarding to PROMs.

Conditions

Interventions

TypeNameDescription
DEVICEUse of XCM for the treatment of MAGRs with mCAF techniqueAfter local anaesthesia, mCAF technique will be performed. XCM will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction.
PROCEDURETreatment of MAGRs with CTGAfter local anaesthesia, mCAF technique will be performed. CTG will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction.

Timeline

Start date
2023-02-02
Primary completion
2024-06-02
Completion
2024-12-02
First posted
2023-01-23
Last updated
2023-06-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05693753. Inclusion in this directory is not an endorsement.